RD SWEET, FH McDOWELL - Annals of Internal Medicine, 1975 - Am Coll Physicians One hundred patients with Parkinson's disease, who started taking levodopa before the end
of 1968, have been assessed after 5 years. Forty-seven patients are still being followed on
levodopa, and half of them are at least 25% better than at their pretreatment evaluation. ... Cited by 58 - Related articles - All 2 versions
C Joseph, JB Chassan, ML Koch - Annals of Neurology, 1978 - interscience.wiley.com Mortality rates for a group of patients in a collaborative multicenter study of levodopa
(Larodopa) in the treatment of parkinsonism were compared with corresponding mortality rates
in the general population adjusted for age and sex distribution in accordance with that of ... Cited by 46 - Related articles - All 2 versions
RJ Marttila, UK Rinne, T Siirtola, V Sonninen - Journal of Neurology, 1977 - Springer Summary. The effect of levodopa on the mortality of patients with Parkinson's disease was investigated
in 349 patients treated with levodopa or levodopa combined with a decarboxylase inhibitor during
1969m1975 inclusive. During the study period, 61 patients died. The expected mortality ... Cited by 48 - Related articles - All 2 versions
H Zumstein, J Siegfried - European Neurology, 1976 - content.karger.com Since L-dopa in combination with a decarboxylase inhibitor is currently the most effective therapy
available for treatment of Parkinson's disease, the authors compare the actual causes of death
in a large series of treated Parkinson patients with a normal population and with previous ... Cited by 42 - Related articles - All 4 versions
SG Diamond, CH Markham - Journal of Neural Transmission, 1976 - Springer Excess mortality, ie more deaths than expected in a similar normal population, has been reduced
in Parkinson's disease by levodopa. A California series and a large colIaborative study throughout
the United States show the ratio of observed to expected deaths to be normai. In contrast, ... Cited by 46 - Related articles - All 2 versions
MM Hoehn - Advances in neurology, 1987 - ncbi.nlm.nih.gov Patients with Parkinson's disease were compared during two 15-year periods before and after
the introduction of levodopa. With levodopa treatment: The duration of illness at each stage of
severity was 3 to 5 years longer; at every duration of illness, death and disability were ... Cited by 39 - Related articles
- ►nih.gov [PDF] CH Markham, LJ Treciokas, SG … - Western Journal of …, 1974 - pubmedcentral.nih.gov Refer to: Markham CH, Treciokas LJ, Diamond SG: Parkinson's disease and levodopa-A five
year follow-up and review (Medical Progress). West J Med 121:188-206, Sep 1974 ... A
Five-Year Follow-up and Review ... CHARLES H. MARKHAM, MD, LEO J. TRECIOKAS, ... Cited by 32 - Related articles - All 3 versions
[CITATION] Parkinsonism treated with levodopa: progression and mortality
A Barbeau - Archives of Neurology, 1976 - archneur.highwire.org Page 1. Six Years of High-Level Levodopa Therapy in Severely Akinetic Parkinsonian
Patients Andr\l=e'\Barbeau, MD, FRCP(C) \s=b\The clinical course and the side effects of
high-level levodopa therapy over a six-year period were studied in 80 ... Cited by 69 - Related articles - All 3 versions
[CITATION] Autopsy findings in parkinsonism following treatment with levodopa
